Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SHS CL A
-
Total 13F shares
-
17,967,898
-
Share change
-
+17,955,400
-
Total reported value
-
$175,188,000
-
Price per share
-
$9.75
-
Number of holders
-
25
-
Value change
-
+$175,066,000
-
Number of buys
-
24
Institutional Holders of AFTERNEXT HEALTHTECH ACQUISI - SHS CL A (AFTR) as of Q4 2021
As of 31 Dec 2021,
AFTERNEXT HEALTHTECH ACQUISI - SHS CL A (AFTR) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,967,898 shares.
The largest 10 holders included
GUGGENHEIM CAPITAL LLC, CITADEL ADVISORS LLC, UBS OCONNOR LLC, FIR TREE CAPITAL MANAGEMENT LP, MILLENNIUM MANAGEMENT LLC, DEUTSCHE BANK AG\, Finepoint Capital LP, MOORE CAPITAL MANAGEMENT, LP, MARSHALL WACE, LLP, and Sculptor Capital LP.
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.